The Bloom syndrome (BS) protein, BLM, is a member of the RecQ DNA helicase
family that also includes the Werner syndrome protein, WRN. Inherited mutat
ions in these proteins are associated with cancer predisposition of these p
atients. We recently discovered that cells from Werner syndrome patients di
splayed a deficiency in p53-mediated apoptosis and WRN binds to p53. Here,
we report that analogous to WRN, BLM also binds to p53 in vivo and in vitro
, and the C-terminal domain of p53 is responsible for the interaction. p53-
mediated apoptosis is defective in BS fibroblasts and can be rescued by exp
ression of the normal BLM gene. Moreover, lymphoblastoid cell lines (LCLs)
derived from BS donors are resistant to both gamma -radiation and doxorubic
in-induced cell killing, and sensitivity can be restored by the stable expr
ession of normal BLM. In contrast, BS cells have a normal Fas-mediated apop
tosis, and in response to DNA damage normal accumulation of p53, normal ind
uction of p53 responsive genes, and normal G(1)-S and G(2)-M Cell cycle arr
est. BLM localizes to nuclear foci referred to as PAM nuclear bodies (NBs).
Cells from Li-Fraumeni syndrome patients carrying p53 germline mutations a
nd LCLs lacking a functional p53 have a decreased accumulation of BLM in NB
s, whereas isogenic lines with functional p53 exhibit normal accumulation.
Certain BLM mutants (C1055S or Delta 133-237) that have a reduced ability t
o localize to the NBs when expressed in normal cells can impair the localiz
ation of wild type BLM to NBs and block p53-mediated apoptosis, suggesting
a dominant-negative effect. Taken together, our results indicate both a nov
el mechanism of p53 function by which p53 mediates nuclear trafficking of B
LM to NBs and the cooperation of p53 and BLM to induce apoptosis.